
False

About Brent Saunders
Brent Saunders
CEO, Allergan
Saunders has significant healthcare industry expertise, and is a previous CEO of Bausch + Lomb, he has also held a number of leadership positions at Schering-Plough and was named head of integration for the company’s merger with Merck & Co. Saunders’ dealmaking is the stuff of legend: he then went on to lead Actavis’ takeover of Allergan, and as CEO of the new entity (dubbed Allergan), Saunders was about to pull off the world’s largest-ever inversion deal: Dublin-based Allergan buying the much larger, New York-based Pfizer, but that deal is now off – as the US government changed the tax laws on inversions.
Explore More in Ophthalmology
Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
Newsletters
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

False
False
False
Disclaimer
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: